Advocating for ROS1


One of the founders of the ROS1ders, Janet Freeman-Daily, shares her story and why she advocates for molecular testing, clinical trials, and the positive changes she’s seen. “Given that lung cancer patients often don’t have much tumor tissue, we should make the best use of it, and running an NGS test is the best chance … Continue reading Advocating for ROS1

The ‘Ross-Wonders’, Cancer’s New Superheroes


You’ve likely never heard the story of how three young women, who call themselves “ROS1ders” from a rare form of lung cancer they share, may be turning the nation’s 46-year-old war on cancer on its head. The women were diagnosed with a gene mutation called a ROS1 fusion. Read more here

The Unnecessary Cruelty of Clinical Trials by: Lisa Goldman


Since I’ve been holding steady on my treatment, I haven’t needed access to a clinical trial yet. However, clinical trials may become essential to my survival, and I’m already concerned about getting into them when I need help the most. I often hear scientists ask, “how can we increase patient participation in clinical trials so … Continue reading The Unnecessary Cruelty of Clinical Trials by: Lisa Goldman

Profiles in Lung Cancer — Day 22, Sandy Arlin Jauregui-Baza [Perfiles en El Cáncer de Pulmón — Día 22, Sandy Arlin Jauregui-Baza]


PROFILES IN LUNG CANCER – DAY 22 Lung Cancer Awareness Month 2015 Sandy Arlin Jauregui-Baza, Survivor and Advocate “Life doesn’t have to end after diagnosis. It can be a wake-up call to start making YOU your biggest priority in life.” [***Por favor, lea la traducción española de abajo***] \Who are you? — I’m a 32 … Continue reading Profiles in Lung Cancer — Day 22, Sandy Arlin Jauregui-Baza [Perfiles en El Cáncer de Pulmón — Día 22, Sandy Arlin Jauregui-Baza]

Profiles in Lung Cancer – Day 21: Dr. Ross Camidge “Progress will come from changing the way we think about cancer”


PROFILES IN LUNG CANCER Lung Cancer Awareness Month 2015 D. Ross Camidge, MD, PhD  “Progress will come from changing the way we think about cancer” Director of the Thoracic Oncology Clinical and Clinical Research Programs, University of Colorado I am incredibly fortunate to have Dr. Ross Camidge as my lung cancer oncologist, clinical trial researcher, advocacy … Continue reading Profiles in Lung Cancer – Day 21: Dr. Ross Camidge “Progress will come from changing the way we think about cancer”